Investigating Potential Claims involving Stemline Therapeutics Inc.
Did you lose money investing in Stemline Therapeutics Inc. at the recommendation of your broker? If so, the securities attorneys at The White Law Group may be able to help you recoup your losses by filing a FINRA Arbitration claim against the brokerage firm that sold you the investment.
Stemline Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, acquisition, development and commercialization of proprietary oncology therapeutics in the United States. The Company is developing “SL-401,” a targeted therapy directed to the interleukin-3 receptor (IL-3R), which is in Phase II clinical trial for advanced hematologic cancers.
Stemline Therapeutics Inc. filed a Form D in 2012 to raise capital in New York, NY.
Are Reg D Private Placements Suitable for you?
Private placements are a means for smaller companies to raise capital through the sale of equity or debt securities without having to register their securities with the SEC. These investments are often riskier and more complicated than traditional investments, and are only suitable for high net worth, sophisticated investors.
Broker dealers are required to perform adequate due diligence on any investment they recommend and to ensure that all recommendations are suitable for the investor. Recommendations should be in line with the investor’s age, risk tolerance, net worth, and investment experience.
Despite the risks of investing in this type of alternative investments, brokerage firms continue to push this type of investment because of the high commissions associated with their sale and creation.
The White Law Group is investigating the liability that FINRA registered brokerage firms may have for improperly selling alternative investment products like Stemline Therapeutics Inc. to their clients.
If you lost money investing in Stemline Therapeutics Inc. or another private placement investment and would like to speak with a securities attorney about your options, please call The White Law Group at 888-637-5510 for a free consultation.
The White Law Group, LLC is a national securities fraud, securities arbitration, investor protection, and securities regulation/compliance law firm with offices in Chicago, Illinois and Franklin, Tennessee.
For more information on The White Law Group and its representation of investors in FINRA arbitration claims, visit https://whitesecuritieslaw.com.
Tags: Chicago securities attorney, Chicago securities lawyer, securities fraud attorney, Stemline Therapeutics Inc. class action, Stemline Therapeutics Inc. complaint, Stemline Therapeutics Inc. complaints, Stemline Therapeutics Inc. dividend, Stemline Therapeutics Inc. history, Stemline Therapeutics Inc. info, Stemline Therapeutics Inc. investigation, Stemline Therapeutics Inc. investment losses, Stemline Therapeutics Inc. lawsuit, Stemline Therapeutics Inc. litigation, Stemline Therapeutics Inc. losses, Stemline Therapeutics Inc. price, Stemline Therapeutics Inc. update, Stemline Therapeutics Inc. value, Stemline Therapeutics Inc. investor relations, Stemline Therapeutics Inc. official, Theranos news, Vero Beach securities attorney, Vero Beach securities lawyer Last modified: August 23, 2017